Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Depression is associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A.

Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22.

PMID:
31328300
2.

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.

Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A.

Nutr Metab Insights. 2019 May 13;12:1178638819847480. doi: 10.1177/1178638819847480. eCollection 2019.

3.

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2019 Oct;157(4):1055-1066.e11. doi: 10.1053/j.gastro.2019.06.026. Epub 2019 Jun 25.

PMID:
31251928
4.

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association.

Li AA, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):260-261. doi: 10.21037/hbsn.2018.12.10. No abstract available.

5.

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Li AA, Ahmed A, Kim D.

Gut Liver. 2019 Jun 17. doi: 10.5009/gnl19069. [Epub ahead of print]

6.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.

7.

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.

Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A.

Liver Int. 2019 Sep;39(9):1661-1671. doi: 10.1111/liv.14135. Epub 2019 Jun 4.

PMID:
31081997
8.

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.

Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A.

Diabetologia. 2019 Jul;62(7):1185-1194. doi: 10.1007/s00125-019-4870-9. Epub 2019 Apr 22.

PMID:
31011776
9.

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Cholankeril G, Tighe SP, Kim W, Harrison SA, Ahmed A.

Liver Int. 2019 Jul;39(7):1335-1342. doi: 10.1111/liv.14110. Epub 2019 Apr 15.

PMID:
30924602
10.

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2019 Feb 25;7(1). pii: E27. doi: 10.3390/diseases7010027. Review.

11.

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.

Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A.

J Clin Transl Hepatol. 2018 Dec 28;6(4):420-424. doi: 10.14218/JCTH.2018.00010. Epub 2018 Jul 28. Review.

12.

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.

Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A.

Hepatol Int. 2019 Jan;13(1):84-90. doi: 10.1007/s12072-018-9918-2. Epub 2018 Dec 12.

13.

Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States.

Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2379-2381. doi: 10.1016/j.cgh.2018.11.024. Epub 2018 Nov 17.

14.

Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations.

Kim D, Li AA, Perumpail RB, Cholankeril G, Gonzalez SA, Kim W, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1607-1615.e2. doi: 10.1016/j.cgh.2018.10.045. Epub 2018 Nov 1.

15.

An Unexpected Colonic Mass.

Li AA, Cholankeril G, Berry GJ, Fernandez-Becker N.

Am J Gastroenterol. 2019 Jan;114(1):180-181. doi: 10.1038/s41395-018-0363-6. No abstract available.

16.

Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States.

Cholankeril G, Gadiparthi C, Yoo ER, Dennis BB, Li AA, Hu M, Wong K, Kim D, Ahmed A.

Transplantation. 2019 Jan;103(1):131-139. doi: 10.1097/TP.0000000000002471.

17.

Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients.

Cholankeril G, Li AA, Dennis BB, Toll AE, Kim D, Bonham CA, Nair S, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1634-1636. doi: 10.1016/j.cgh.2018.09.036. Epub 2018 Sep 27.

18.

The Role of Vitamin E in the Treatment of NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 24;6(4). pii: E86. doi: 10.3390/diseases6040086. Review.

19.

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 19;6(3). pii: E83. doi: 10.3390/diseases6030083. Review.

20.

Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.

Farooqui MT, Khan MA, Cholankeril G, Khan Z, Mohammed Abdul MK, Li AA, Shah N, Wu L, Haq K, Solanki S, Kim D, Ahmed A.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):149-156. doi: 10.1097/MEG.0000000000001263.

Supplemental Content

Loading ...
Support Center